TRANSIENT NEONATAL PUSTULAR MELANOSIS

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting TRANSIENT NEONATAL PUSTULAR MELANOSIS:

# Drug Count
0 ATAZANAVIR 3
1 ATAZANAVIR AND COBICISTAT 3
2 RITONAVIR 3
3 RITONAVIR 100 MG 3
4 ABACAVIR AND LAMIVUDINE 2
5 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 1
6 ERYTHROMYCIN 1
See all common drugs associated with TRANSIENT NEONATAL PUSTULAR MELANOSIS

TRANSIENT NEONATAL PUSTULAR MELANOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ATAZANAVIR AND COBICISTAT 3 0.0122
1 ABACAVIR AND LAMIVUDINE 2 0.0100
2 ATAZANAVIR 3 0.0002
3 RITONAVIR 100 MG 3 0.0002
4 ERYTHROMYCIN 1 0.0001
5 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 1 0.0000
See all drugs enriched for association with TRANSIENT NEONATAL PUSTULAR MELANOSIS